Key result
Mechanical circulatory support with veno-arterial extracorporeal life support and Impella led to full recovery in a 30-year-old woman with COVID-19 and cardiogenic shock.
Why the study?
Severe cardiac failure due to COVID-19 appears to be rare, and the precise aetiology of SARS-CoV-2-related myocarditis remains to be elucidated.
Case Report (n=1)
No
Mechanical circulatory support with VA-ECMO and Impella venting successfully treated severe cardiogenic shock due to probable SARS-CoV-2 myocarditis.
Raises awareness for fulminant myocarditis causing shock in young COVID-19 patients; leaves open optimal ECLS timing and selection criteria.
Background: Since the start of the COVID-19 pandemic, many case reports have been presented describing different cardiac symptoms due to the SARS-CoV-2 infection. However, severe cardiac failure due to COVID-19 seems to be rare. Case summary: A 30-year-old woman presented with COVID-19 and cardiogenic shock due to a lymphocytic myocarditis. Since she deteriorated under treatment with inotropes, she was referred to our centre, and veno-arterial extracorporeal life support was started. Subsequently, the aortic valve only opened sporadically, and spontaneous contrast appeared in the left ventricle (LV), pointing towards difficulties with unloading LV. Therefore, an Impella for venting the LV was implanted. After 6 days of mechanical circulatory support, her heart function recovered. All support could be weaned, and 2 months later, she had made a full recovery. Discussion: We presented a patient with severe cardiogenic shock due to an acute virus-negative lymphocytic myocarditis associated with a SARS-CoV-2 infection. Since the precise aetiology of SARS-CoV-2-related myocarditis remains to be elucidated and no virus could be detected in the heart, a causal relationship remains speculative.
No takes yet. Share an insight, caveat, or question.
Klasen et al. (2023) conducted a case report in COVID-19 and cardiogenic shock due to lymphocytic myocarditis (n=1). Veno-arterial extracorporeal life support and Impella was evaluated on Heart function recovery. Mechanical circulatory support with veno-arterial extracorporeal life support and Impella led to full recovery in a 30-year-old woman with COVID-19 and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: